Pulsatile vs. continuous parenteral tocolysis: comparison of side effects.
Bolus tocolysis has been developed to reduce the dose of fenoterol compared to continuous tocolysis. Whereas the high efficacy of pulsatile application of fenoterol has been shown, the proof of reduced side effects is still lacking. A total of 59 patients with preterm labor were divided in three groups: (1) continuous tocolysis and oral application of magnesium (n=19), (2) continuous tocolysis and parenteral application of magnesium (n=20), (3) pulsatile tocolysis (bolus tocolysis) and oral application of magnesium (n=20). Heart rate, systolic and diastolic blood pressure, serum K+ and serum Mg++ were quantified before tocolysis and after 2, 8 and 24 h. Beta-blockers and water balance were recorded over 24 h. Subjective side effects were quantified using a questionnaire with scales graduated covering palpitations, tremor, diaphoresis, thirst, precardialgia and nausea/vomiting. The analysis of the data revealed significantly fewer side effects concerning heart rate, plasma K+ level and the subjective side effects among patients treated with bolus tocolysis than among those treated with continuous tocolysis. Between the latter two groups, no significant difference was found. Concerning blood pressure and need for beta-blockers, no significant differences were found between the three groups. The results of the present study show that especially the side effects subjectively found to be disagreeable by the patients are reduced by pulsatile tocolysis, whereas other side effects show only slight differences between the study groups.
Herzog
S
S
Dept. Obstet. Gynaecol., Georg-August-Universität, Göttingen, Germany.
Cunze
T
T
Martin
M
M
Osmers
R
R
Gleiter
C
C
Kuhn
W
W
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001794:Blood Pressure; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage* / Q000009:adverse effects; D006339:Heart Rate; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects; D008274:Magnesium / Q000008:administration & dosage / Q000097:blood; D011188:Potassium / Q000097:blood; D011247:Pregnancy; D015145:Tocolysis / Q000009:adverse effects* / Q000379:methods*; D015149:Tocolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D015149:Tocolytic Agents; D005280:Fenoterol; D008274:Magnesium; D011188:Potassium